» Articles » PMID: 32175140

Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC),...

Abstract

Infective endocarditis (IE) is rare, but associated with significant morbidity and mortality rates. Estimates of the incidence of IE in Turkey are compromised by the absence of population-based prospective studies. Due to the frequent presence of predisposing cardiac conditions and higher rates of nosocomial bacteremia in highrisk groups, the incidence of IE is expected to be higher in Turkey. Additionally, while IE generally affects older people in developed countries, it still affects young people in Turkey. In order to reduce the mortality and morbidity, it is critical to diagnose the IE to determine the causative agent and to start treatment rapidly. However, most of the patients cannot be diagnosed in their first visits, about half of them can be diagnosed after three months, and the disease often goes unnoticed. In patients diagnosed with IE, the rate of identification of causative organisms is significantly lower in Turkey than in developed countries. Furthermore, most of the centers do not perform some essential microbiological diagnostic tests as a routine practice. Some antimicrobials that are recommended as the first-line of treatment for IE, particularly antistaphylococcal penicillins, are not available in Turkey. These problems necessitate reviewing the epidemiological, laboratory, and clinical characteristics of IE in our country, as well as the current information about its diagnosis, treatment, and prevention together with local data. Physicians can follow patients with IE in many specialties. Diagnosis and treatment processes of IE should be standardized at every stage so that management of IE, a setting in which many physicians are involved, can always be in line with current recommendations. Study Group for Infective Endocarditis and Other Cardiovascular Infections of the Turkish Society of Clinical Microbiology and Infectious Diseases has called for collaboration of the relevant specialist organizations to establish a consensus report on the diagnosis, treatment, and prevention of IE in the light of current information and local data in Turkey.

Citing Articles

Non-bacterial thrombotic endocarditis in long-standing primary hypoparathyroidism: A case report.

Eroglu T, Durdu N, Arslanhan G, Senay S, Alhan C Turk Gogus Kalp Damar Cerrahisi Derg. 2024; 32(3):333-336.

PMID: 39513162 PMC: 11538929. DOI: 10.5606/tgkdc.dergisi.2024.24908.


Application of Metagenomic Next-Generation Sequencing in the Etiological Diagnosis of Infective Endocarditis During the Perioperative Period of Cardiac Surgery: A Prospective Cohort Study.

Zeng X, Wu J, Li X, Xiong W, Tang L, Li X Front Cardiovasc Med. 2022; 9:811492.

PMID: 35369282 PMC: 8965566. DOI: 10.3389/fcvm.2022.811492.

References
1.
Bai A, Showler A, Burry L, Steinberg M, Ricciuto D, Fernandes T . Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study. J Antimicrob Chemother. 2015; 70(5):1539-46. DOI: 10.1093/jac/dku560. View

2.
Lopez J, Sevilla T, Vilacosta I, Sarria C, Revilla A, Ortiz C . Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis. Eur Heart J. 2012; 34(23):1749-54. DOI: 10.1093/eurheartj/ehs379. View

3.
Fernandez-Hidalgo N, Almirante B, Tornos P, Pigrau C, Sambola A, Igual A . Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis. 2008; 47(10):1287-97. DOI: 10.1086/592576. View

4.
Kahveci G, Bayrak F, Mutlu B, Bitigen A, Karaahmet T, Sonmez K . Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis. Am J Cardiol. 2007; 99(10):1429-33. DOI: 10.1016/j.amjcard.2006.12.071. View

5.
Mahr A, Batteux F, Tubiana S, Goulvestre C, Wolff M, Papo T . Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. Arthritis Rheumatol. 2014; 66(6):1672-7. DOI: 10.1002/art.38389. View